Contact Us
Zaltrap Global Market Report 2025
Global Zaltrap Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Zaltrap Global Market Report 2025

By Indication (Metastatic Colorectal Cancer (mCRC), Metastatic Breast Cancer), By Formulation (Injection (100 mg/4 mL, 200 mg/8 mL)), By Distribution Channel (Hospitals, Oncology Clinics, Pharmacies), By End-User (Adult Patients, Geriatric Patients)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Zaltrap Market?

Zaltrap is a prescription medication used with other chemotherapy drugs to treat metastatic colorectal cancer (mCRC). It is a VEGF inhibitor that blocks VEGF-A, VEGF-B, and placental growth factor (PlGF), preventing angiogenesis and the formation of new blood vessels that tumors require to grow and spread, thereby slowing disease progression.

The main types of indication for zaltrap are metastatic colorectal cancer (mCRC) and Metastatic Breast Cancer. Metastatic colorectal cancer (mCRC) is a late stage of colorectal cancer in which the disease has spread to distant organs, such as the liver or lungs. It comes in formulations such as injections (100 mg/4 ml, 200 mg/8 ml) and is distributed through various distribution channels, including hospitals, oncology clinics, and pharmacies. It is used by several end users, including adult patients and geriatric patients.

Zaltrap Market Size and growth rate 2025 to 2029: Graph

What Is The Zaltrap Market Size 2025 And Growth Rate?

The zaltrap market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising demand for effective cancer therapies, rising number of clinical trials, increasing healthcare expenditure, growing emphasis on personalized medicine approaches, and increasing patient population with treatment-resistant cancer.

What Is The Zaltrap Market Growth Forecast?

The zaltrap market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising incidence of colorectal cancer globally, increasing government initiatives supporting cancer research funding, growth of patient-centric initiatives, rising global focus on cancer research funding, and rising prevalence of co-morbid conditions. Major trends in the forecast period include advancements in drug delivery systems, advancements in imaging technologies, advancements in biomarker identification, integration of artificial intelligence in drug development processes, and advancements in nanotechnology.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Zaltrap Market Segmented?

The zaltrap market covered in this report is segmented –

1) By Indication: Metastatic Colorectal Cancer (mCRC); Metastatic Breast Cancer

2) By Formulation: Injection (100 mg/4 mL, 200 mg/8 mL)

3) By Distribution Channel: Hospitals; Oncology Clinics; Pharmacies

4) By End-User: Adult Patients; Geriatric Patients

What Is Driving The Zaltrap Market? Rising Prevalence Of Colorectal Cancer Fuel Demand For The Market

The increasing prevalence of colorectal cancer is expected to propel the growth of the zaltrap market going forward. Colorectal cancer is a type of cancer that originates in the colon or rectum, typically beginning as benign polyps and potentially advancing if not addressed. The prevalence of colorectal cancer is rising due to factors such as an aging population, unhealthy diets, obesity and overweight, and genetic predisposition. Zaltrap is a vascular endothelial growth factor (VEGF) inhibitor that prevents the formation of new blood vessels (angiogenesis), cutting off the tumor's blood supply. This action helps slow disease progression and enhances survival outcomes in colorectal cancer patients. For instance, in July 2024, according to a report published by Bowel Cancer UK, a UK-based bowel cancer charitable organization, around 44,000 people are diagnosed with bowel cancer each year in the UK. More than 90% of these new cases (94%) are found in individuals aged 50 and older; however, bowel cancer can impact people of any age, with over 2,600 new cases diagnosed annually in those under 50. Therefore, the increasing prevalence of colorectal cancer is driving the growth of the zaltrap market.

What Is Driving The Zaltrap Market? Rising Cancer Care Expenditure Boosts Growth Of The Market

The increasing expenditure on cancer care is set to propel the growth of the zaltrap market moving forward. Cancer care expenditure includes all costs related to the prevention, diagnosis, treatment, and follow-up care of cancer, covering both medical and non-medical expenses. Increasing expenditure on cancer care is driven by the rising incidence of cancer, advancements in medical technology and treatments, and the growing number of cancer survivors requiring long-term management. As cancer care spending increases, the focus intensifies on targeted and effective treatments, while enhanced research and clinical trials drive the development and adoption of ZALTRAP. For instance, in September 2024, according to a report published by Cancer Research UK, a UK-based charitable funder of cancer research, in the financial year 2023/24, £399 million ($414.65) was spent on cancer research, with £93 million ($96.64) allocated to research addressing all types of cancer and £84 million ($87.29) directed towards basic research to explore the fundamental biology of cancer. Therefore, the increasing expenditure on cancer care is driving the growth of the zaltrap market.

What Is Driving The Zaltrap Market? Impact Of The Growing Aging Population On The Market Growth

The growing aging population is significantly driving the growth of the zaltrap market in the future. An aging population is a demographic shift characterized by a growing percentage of individuals aged 60 or 65 and above within a population. The growing aging population is driven by factors such as declining fertility rates, increased life expectancy, social services, and economic structures to better support and engage this demographic. Zaltrap provides an effective treatment for metastatic colorectal cancer, which is more prevalent in the aging population. By blocking VEGF and inhibiting tumor growth, it helps improve outcomes, slow progression, and enhance the quality of life for older cancer patients. For instance, in January 2024, according to the Population Reference Bureau, a Kenya-based nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. Therefore, the growing aging population is driving the growth of the zaltrap market.

Who Are The Major Players In The Global Zaltrap Market?

Major companies operating in the zaltrap market are Sanofi S.A.

Need data on a specific region in this market?

Regional Analysis For The Global Zaltrap Market

North America was the largest region in the zaltrap market in 2024. The regions covered in the zaltrap market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zaltrap market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zaltrap Market?

The zaltrap market consists of sales of single-dose vials, prefilled syringes, and lyophilized powder for reconstitution. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Zaltrap Industry?

The zaltrap market research report is one of a series of new reports from The Business Research Company that provides zaltrap market statistics, including the zaltrap industry global market size, regional shares, competitors with the zaltrap market share, detailed zaltrap market segments, market trends, and opportunities, and any further data you may need to thrive in the zaltrap industry. This zaltrap market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Zaltrap Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The zaltrap market covered in this report is segmented –
1) By Indication: Metastatic Colorectal Cancer (mCRC); Metastatic Breast Cancer
2) By Formulation: Injection (100 mg/4 mL, 200 mg/8 mL)
3) By Distribution Channel: Hospitals; Oncology Clinics; Pharmacies
4) By End-User: Adult Patients; Geriatric Patients
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi S.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Zaltrap Market Characteristics

3. Zaltrap Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Zaltrap Market Trends And Strategies

5. Zaltrap Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Zaltrap Growth Analysis And Strategic Analysis Framework

6.1. Global Zaltrap PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Zaltrap Market Growth Rate Analysis

6.4. Global Zaltrap Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Zaltrap Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Zaltrap Total Addressable Market (TAM)

7. Global Zaltrap Pricing Analysis & Forecasts

8. Zaltrap Market Segmentation

8.1. Global Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Metastatic Colorectal Cancer (mCRC)

Metastatic Breast Cancer

8.2. Global Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Injection (100 mg/4 mL, 200 mg/8 mL)

8.3. Global Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Oncology Clinics

Pharmacies

8.4. Global Zaltrap Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult Patients

Geriatric Patients

9. Global Zaltrap Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Zaltrap Market Regional And Country Analysis

10.1. Global Zaltrap Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Zaltrap Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Zaltrap Market

11.1. Asia-Pacific Zaltrap Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Zaltrap Market

12.1. China Zaltrap Market Overview

12.2. China Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Zaltrap Market

13.1. India Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Zaltrap Market

14.1. Japan Zaltrap Market Overview

14.2. Japan Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Zaltrap Market

15.1. Australia Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Zaltrap Market

16.1. South Korea Zaltrap Market Overview

16.2. South Korea Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Zaltrap Market

17.1. Western Europe Zaltrap Market Overview

17.2. Western Europe Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Zaltrap Market

18.1. UK Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Zaltrap Market

19.1. Germany Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Zaltrap Market

20.1. France Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Zaltrap Market

21.1. Eastern Europe Zaltrap Market Overview

21.2. Eastern Europe Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Zaltrap Market

22.1. North America Zaltrap Market Overview

22.2. North America Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Zaltrap Market

23.1. USA Zaltrap Market Overview

23.2. USA Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Zaltrap Market

24.1. Canada Zaltrap Market Overview

24.2. Canada Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Zaltrap Market

25.1. South America Zaltrap Market Overview

25.2. South America Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Zaltrap Market

26.1. Middle East Zaltrap Market Overview

26.2. Middle East Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Zaltrap Market

27.1. Africa Zaltrap Market Overview

27.2. Africa Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Zaltrap Market Competitive Landscape And Company Profiles

28.1. Zaltrap Market Competitive Landscape

28.2. Zaltrap Market Company Profiles

28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

29. Global Zaltrap Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Zaltrap Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Zaltrap Market

32. Recent Developments In The Zaltrap Market

33. Zaltrap Market High Potential Countries, Segments and Strategies

33.1 Zaltrap Market In 2029 - Countries Offering Most New Opportunities

33.2 Zaltrap Market In 2029 - Segments Offering Most New Opportunities

33.3 Zaltrap Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Zaltrap Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Zaltrap Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Zaltrap Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Sanofi S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Zaltrap Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Zaltrap Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Zaltrap Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Zaltrap Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Zaltrap Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Zaltrap Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Sanofi S.A. Financial Performance

Frequently Asked Questions

Zaltrap is a prescription medication used with other chemotherapy drugs to treat metastatic colorectal cancer (mCRC). It is a VEGF inhibitor that blocks VEGF-A, VEGF-B, and placental growth factor (PlGF), preventing angiogenesis and the formation of new blood vessels that tumors require to grow and spread, thereby slowing disease progression. For further insights on the Zaltrap market, request a sample here

The Zaltrap market major growth driver - Rising Prevalence Of Colorectal Cancer Fuel Demand For The Market. For further insights on the Zaltrap market, request a sample here

The Zaltrap market size has grown strongly in recent years. The zaltrap market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising demand for effective cancer therapies, rising number of clinical trials, increasing healthcare expenditure, growing emphasis on personalized medicine approaches, and increasing patient population with treatment-resistant cancer. The zaltrap market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising incidence of colorectal cancer globally, increasing government initiatives supporting cancer research funding, growth of patient-centric initiatives, rising global focus on cancer research funding, and rising prevalence of co-morbid conditions. Major trends in the forecast period include advancements in drug delivery systems, advancements in imaging technologies, advancements in biomarker identification, integration of artificial intelligence in drug development processes, and advancements in nanotechnology. For further insights on the Zaltrap market, request a sample here

The zaltrap market covered in this report is segmented –
1) By Indication: Metastatic Colorectal Cancer (mCRC); Metastatic Breast Cancer
2) By Formulation: Injection (100 mg/4 mL, 200 mg/8 mL)
3) By Distribution Channel: Hospitals; Oncology Clinics; Pharmacies
4) By End-User: Adult Patients; Geriatric Patients For further insights on the Zaltrap market,
request a sample here

North America was the largest region in the zaltrap market in 2024. The regions covered in the zaltrap market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Zaltrap market, request a sample here.

Major companies operating in the zaltrap market are Sanofi S.A. . For further insights on the Zaltrap market, request a sample here.

Major trends in the Zaltrap market include . For further insights on the Zaltrap market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon